Lisa Porter and John Trant, shown in this 2019 photo, have received funding through the Windsor Cancer Centre Foundation’s Seeds4Hope program to devise new imaging agents for the diagnosis of prostate cancer.
Lisa Porter and John Trant are working to devise new imaging agents for the diagnosis of prostate cancer.
“Go Grey in May” is a national campaign to raise awareness of brain tumours.
“Go Grey in May” is a national campaign to raise awareness of brain tumours.
Professors Jill Urbanic and John Trant will propose potential research projects at an upcoming WE-Spark think tank event.
Professors Jill Urbanic and John Trant will propose potential research projects at an upcoming WE-Spark think tank event.
Lisa Porter and John Trant, shown in this 2019 photo, have received another $250,000 in research funding from the Ontario Institute for Cancer Research.
Lisa Porter and John Trant have received a further $250,000 in funding from the Ontario Institute for Cancer Research.
Chemistry professor John Trant has received a $50,000 grant from the Brain Tumour Foundation of Canada to launch research into cancer-fighting nanoparticles that kill tumours by tricking the brain’s defences.
Researcher John Trant is exploring the use of nanoparticles to fight cancer by tricking the brain’s defences.
Important Update on vaccination policy & accessing campus
UWindsor students will host an online panel discussion Feb. 19 to address public concerns about receiving inoculation against COVID-19.
Professor John Trant is working to develop a simple test to determine whether a vaccine has effected immunity to COVID-19.
Professor John Trant is working to develop a simple test to determine whether a vaccine has effected immunity to COVID-19.
A webinar Nov. 19 will introduce the Proteus reverse business pitch competition.
A webinar Nov. 19 will introduce the Proteus reverse business pitch competition.
Biochemist John Trant is heading up a research team exploring the behaviours of disease-causing proteins.
Biochemist John Trant is heading up a research team exploring the behaviours of disease-causing proteins.
John Trant has been awarded a grant from the Natural Sciences and Engineering Research Council of Canada to design a new drug to fight coronaviruses like the one that causes COVID-19.
A UWindsor chemist is working to design a new drug to fight coronaviruses like the one that causes COVID-19.
